Skip to main content
. 2022 Oct 2;22:300. doi: 10.1186/s12935-022-02725-5

Fig. 6.

Fig. 6

Nomogram for patients with NV-HCC in the development cohort (A) and the validation cohort (B). Calibration curves of the nomogram for OS in the two cohort (C, D). Restricted mean survival (RMS) curves for the prognostic model and nomogram in the development cohort (E) and the validation cohort (F)